← FDA Drug Approvals (Drugs@FDA)

LYRICA

NDA · New Drug Application · Sponsor: CP PHARMS · Approved 2004-12-30

Drug application

FDA Application #

NDA021723

Application type

New Drug Application

Brand name

LYRICA

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

CP PHARMS

First approval

2004-12-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown